| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net revenue | 53,843 | - |
| Cost of goods sold | 23,182 | - |
| Variable sales costs | 24,561 | - |
| Other vendor and payroll expenses | 13,490 | - |
| Depreciation and amortization | 1,218 | - |
| Stock-based compensation expense | 1,636 | - |
| Other segment items | -793 | - |
| Net loss | -11,037 | -8,756 |
| Depreciation and amortization | 1,218 | 812 |
| Provision for sales returns | -89 | -49 |
| Amortization of deferred financing cost and debt discounts | 116 | 75 |
| Stock-based compensation | 1,636 | 905 |
| Deferred tax expense | 0 | 0 |
| Change in inventory provisions | 543 | 574 |
| Change in fair value of warrant liabilities | -108 | -90 |
| Allowance for credit losses | -147 | -147 |
| Accounts receivable | -1,465 | -897 |
| Inventory | 3,951 | 5,322 |
| Prepaid and other current assets | 67 | 91 |
| Accounts payable, accrued and other liabilities | 568 | 2,905 |
| Cash (used in) provided by operating activities | -9,853 | -8,287 |
| Purchase of fixed assets | 46 | 6 |
| Purchase of minority equity investment | 0 | 0 |
| Cash used in investing activities | -46 | -6 |
| Repayments on seller notes | 113 | 113 |
| Borrowings from midcap credit facilities | 36,176 | 23,424 |
| Repayments for midcap credit facilities | 37,025 | 23,220 |
| Insurance obligation payments | 611 | 409 |
| Insurance financing proceeds | 706 | 706 |
| Cash used in financing activities | -867 | 388 |
| Foreign currency effect on cash and restricted cash | 350 | 448 |
| Net change in cash and restricted cash for the period | -10,416 | -7,457 |
| Cash and cash equivalents at beginning of period | 19,143 | - |
| Cash and cash equivalents at end of period | 8,727 | - |
Aterian, Inc. (ATER)
Aterian, Inc. (ATER)